TETRAPHASE PHARMACEUTICALS I's ticker is and the CUSIP is 88165N905. A total of 3 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $0 | -100.0% | 712 | -1.0% | 0.00% | – |
| Q1 2019 | $96,000 | +9500.0% | 719 | +4393.8% | 0.00% | – |
| Q4 2018 | $1,000 | -99.5% | 16 | -98.0% | 0.00% | -100.0% |
| Q3 2018 | $215,000 | +726.9% | 781 | +969.9% | 0.00% | – |
| Q2 2018 | $26,000 | +766.7% | 73 | +25.9% | 0.00% | – |
| Q1 2018 | $3,000 | -91.2% | 58 | -95.0% | 0.00% | -100.0% |
| Q3 2017 | $34,000 | -22.7% | 1,171 | +92.3% | 0.00% | -50.0% |
| Q2 2017 | $44,000 | -61.7% | 609 | +49.6% | 0.00% | -60.0% |
| Q1 2017 | $115,000 | +2775.0% | 407 | +133.9% | 0.01% | – |
| Q4 2016 | $4,000 | -20.0% | 174 | +35.9% | 0.00% | – |
| Q3 2016 | $5,000 | -64.3% | 128 | -31.2% | 0.00% | -100.0% |
| Q2 2016 | $14,000 | -72.0% | 186 | -67.9% | 0.00% | -75.0% |
| Q1 2016 | $50,000 | -12.3% | 579 | +15.6% | 0.00% | 0.0% |
| Q4 2015 | $57,000 | +78.1% | 501 | -45.7% | 0.00% | +100.0% |
| Q3 2015 | $32,000 | -3.0% | 923 | +1906.5% | 0.00% | -33.3% |
| Q2 2015 | $33,000 | +106.2% | 46 | +119.0% | 0.00% | +50.0% |
| Q1 2015 | $16,000 | -80.2% | 21 | -57.1% | 0.00% | -80.0% |
| Q4 2014 | $81,000 | – | 49 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 17,300 | $821,000 | 0.01% |
| SIMPLEX TRADING, LLC | 46 | $33,000 | 0.00% |
| Citadel Advisors | 7,200 | $342,000 | 0.00% |